Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment

Saved in:
Bibliographic Details
Main Authors: Schwarzbich, Mark-Alexander (Author) , Schöning, Tilman (Author) , Cremer, Martin (Author) , Kriegsmann, Katharina (Author) , Ho, Anthony Dick (Author) , Witzens-Harig, Mathias (Author)
Format: Article (Journal) Editorial
Language:English
Published: 16 Mar 2016
In: Leukemia and lymphoma
Year: 2016, Volume: 57, Issue: 7, Pages: 1723-1726
ISSN:1029-2403
DOI:10.3109/10428194.2015.1113274
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3109/10428194.2015.1113274
Verlag, lizenzpflichtig, Volltext: https://www.tandfonline.com/doi/full/10.3109/10428194.2015.1113274
Get full text
Author Notes:Mark-Alexander Schwarzbich, Tilman Schöning, Martin Cremer, Katharina Lisenko, Anthony D. Ho, Matthias Witzens-Harig
Description
Item Description:Gesehen am 26.05.2020
Physical Description:Online Resource
ISSN:1029-2403
DOI:10.3109/10428194.2015.1113274